RxDoctor Payments Data

Benjamin Savasky, DPM

Podiatrist · Irvine, CANPI 1700240090

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.9%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. Stryker accounts for 80.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $4,894 and has fallen 96.3% since, to $180 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,555in general payments, 2019–2025

Across 166 payments — averaging $99.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$13K
  • Bioness Inc$1K
  • Musculoskeletal Transplant Foundation Inc.$527
  • Johnson & Johnson$341
  • Nevro Corp.$269
  • Integra Lifesciences Corporation$235
  • plus $579 from 6 others

What the payments were for

  • Travel & lodging$6,03136%
  • Food & beverage$9,41757%
  • Education$5103%
  • Entertainment$5984%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker138$13,360
Bioness Inc3$1,245
Musculoskeletal Transplant Foundation Inc.6$527
Johnson & Johnson5$341
Nevro Corp.3$269
Integra Lifesciences Corporation3$235
Bioventus LLC2$151
Biotissue Holdings Inc.1$139
Saxum Surgical, Inc.1$106
Paragon 28, Inc.1$85
Medtronic2$50
AMDT Holdings, Inc.1$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,555 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$878,098
Medicare patients
86
Services billed
913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate163$3,026
Terbinafine Hcl154$2,602
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip73$1,326
Ketoconazole39$960
Gabapentin100$774
Methylprednisolone99$569
Diclofenac Sodium33$516
Ciclopirox14$316
Doxycycline Hyclate58$293
Ondansetron OdtOndansetron13$157
Meloxicam21$139
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$61
Levofloxacin18$41

Paid to pharmacies, not to this prescriber.

Other podiatrist in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →